We examined the relationships between GIRKI gene expression and AMF-R gene expression, known as a marker of lymph node metastasis and tumor progression in NSCLC [12], and the results of GIRK1 gene expression agreed significantly with AMF-R. This evidence concerns the gene AMFR and neoplasm.